Chinese Markets for Bladder Cancer Treatment Drugs

Publication Date	September 2009
Publisher	AMID
Product Type	Report
Pages	200
ISBN Number	not applicable
Product Code	AMI00421

Buy this product or for assistance call +44 20 7060 7474

PDF £2,405.00$4001 | €2692

FAX Order above formats by FAX

Summary

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Content

I. Introduction
- Report Scope and Methodology
- Executive Summary
II. Business Environment
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. Bladder Cancer Treatment Drugs Industry Assessments
- Bladder Cancer Treatment Drugs Industry Structure
- Market Size
- Market Growth Drivers
- Bladder Cancer Treatment Drugs Sales Volume
- Major Producer Facility Locations
- Major Producers' Sales Volume and Market Share
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investment
- Technology Development
IV. Bladder Cancer Treatment Drugs Production and Demand
- Bladder Cancer Overview
- Bladder Cancer Treatment Drugs Market Overview
- Bladder Cancer Treatment Drugs Market Overview by Classification
- Intraluminal Perfusion Agents
- Unilateral Chemotherapy Drug
- First-Line Chemotherapy Drug
- Immunomodulator
- Other Drugs
- Bladder Cancer Treatment Drugs Import and Export by Classification
- Bladder Cancer Treatment Drugs Import
- Bladder Cancer Treatment Drugs Export
- Market Overview by Drug's Active Principle
- Market Overview by Producers
- Pricing Trend
V. Bladder Cancer Treatment Drugs Market Outlook
- Bladder Cancer Treatment Drugs Markets Outlook Overview
- Government Regulation
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
VI. Marketing Strategies
- China Market Entry Overview
- China's Distribution System
- Bladder Cancer Treatment Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Export to China
- Indirect Export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. Bladder Cancer Treatment Drugs Producer Directory
- Profiles of Bladder Cancer Treatment Drugs Producers
List of Tables
I. Introduction
- Economic Outlook Summary
II. Business Environment
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
III. Bladder Cancer Treatment Drugs Industry Assessments
- Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008
- Bladder Cancer Treatment Drugs Sales Volume
- Major Producer Facility Location
- Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share in 2008
- Major Foreign Investment in China
IV. Bladder Cancer Treatment Drugs Production and Demand
- Bladder Cancer Treatment Drugs Import by Country in 2008
- Bladder Cancer Treatment Drugs Export by Country in 2008
- Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
- Bladder Cancer Treatment Drugs Import by Drugs Classification
- Bladder Cancer Treatment Drugs Export by Drugs Classification
- Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share in 2008
- Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share in 2008
- Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008
V. Bladder Cancer Treatment Drugs Market Outlook
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
List of Charts
I. Introduction
- Bladder Cancer Treatment Drugs Sales Volume
II. Business Environment
- China's Gdp and Growth Rate
- Industrial Output by Ownership
- China's Imports and Exports
III. Bladder Cancer Treatment Drugs Industry Assessments
- Bladder Cancer Treatment Drugs Sales Volume
- Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
- Top 14 Bladder Cancer Treatment Drugs Market Share in 2008
IV. Bladder Cancer Treatment Drugs Production and Demand
- Bladder Cancer Treatment Drugs Sales Volume
- Bladder Cancer Treatment Drugs Import
- Bladder Cancer Treatment Drugs Import by Country in 2008
- Bladder Cancer Treatment Drugs Export
- Bladder Cancer Treatment Drugs Export by Country in 2008
- Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008
- Intraluminal Perfusion Agents Sales Volume and Market Share
- Unilateral Chemotherapy Drug Sales Volume and Market Share
- First-Line Chemotherapy Drug Sales Volume and Market Share
- Immunomodulator Sales Volume and Market Share
- Other Drugs Sales Volume and Market Share
- Bladder Cancer Treatment Drugs Import by Classification in 2008
- Unilateral Chemotherapy Drug Import and Market Share
- First-Line Chemotherapy Drug Import and Market Share
- Intraluminal Perfusion Agents Import and Market Share
- Immunomodulator Import and Market Share
- Other Drugs Import and Market Share
- Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008
- Unilateral Chemotherapy Drug Export and Market Share
- First-Line Chemotherapy Drug Export and Market Share
- Intraluminal Perfusion Agents Export and Market Share
- Immunomodulator Export and Market Share
VI. Marketing Strategies
- China's Distribution Channel